Department of Surgery, University of Kansas, Wichita, Kansas.
J Neurosurg. 2016 Oct;125(4):982-985. doi: 10.3171/2015.8.JNS15396. Epub 2016 Jan 8.
OBJECTIVE There is little information on the frequency of symptomatic epidural hematomas after the implantation of paddle spinal cord stimulators (SCSs) in the thoracic spine. The purpose of this paper is to provide this metric and compare it to the frequency of symptomatic epidural hematomas for all other thoracic laminectomies combined. METHODS This study involved retrospectively analyzing the experience of a single surgeon in a consecutive series of patients who underwent the implantation of a thoracic paddle SCS with respect to the occurrence of a symptomatic epidural hematoma. For comparison, the occurrence of a symptomatic epidural hematoma in non-SCS thoracic laminectomies done during the same period of time was determined. RESULTS One hundred fifty-four thoracic paddle SCSs were implanted between May 2002 and February 2015. Despite perfect hemostasis and no preoperative risk factors, 4 of 154 patients (2.60%) developed postoperative lower-extremity weakness caused by an epidural hematoma. There were no other causes of a neurological deficit. In 3 of the 4 patients, the symptoms were delayed. Over the same time period, only 1 of 119 patients (0.84%) developed a postoperative motor deficit from a symptomatic epidural hematoma after a non-SCS laminectomy. CONCLUSIONS The occurrence of epidural hematomas after thoracic paddle SCS implantation may be underreported. Suggestions are given to decrease its incidence. It seems paradoxical that an epidural hematoma occurred 3 times more often after small SCS thoracic laminectomies than after larger non-SCS thoracic laminectomies. If confirmed by future studies, this finding may suggest that the intrusion of instruments into a confined epidural sublaminar space or the presence of a paddle and a hematoma in this restricted space may account for this differential.
在胸椎植入桨式脊髓刺激器(SCS)后,有关症状性硬膜外血肿的发生频率的信息很少。本文的目的是提供这一指标,并将其与所有其他胸椎椎板切除术的症状性硬膜外血肿发生频率进行比较。
本研究回顾性分析了一位外科医生在连续系列接受胸椎桨式 SCS 植入术的患者中,出现症状性硬膜外血肿的情况。为了进行比较,确定了同期行非 SCS 胸椎椎板切除术时出现症状性硬膜外血肿的发生情况。
2002 年 5 月至 2015 年 2 月期间共植入了 154 个胸椎桨式 SCS。尽管止血完美且无术前危险因素,但仍有 4 例(2.60%)患者术后出现硬膜外血肿导致下肢无力。无其他神经功能缺损的原因。在 4 例患者中,有 3 例症状延迟。在同一时期,仅 1 例(0.84%)非 SCS 椎板切除术患者在术后出现症状性硬膜外血肿导致运动功能障碍。
胸椎桨式 SCS 植入后硬膜外血肿的发生可能被低估。提出了减少其发生率的建议。令人感到矛盾的是,在较小的 SCS 胸椎椎板切除术之后,硬膜外血肿的发生率比较大的非 SCS 胸椎椎板切除术高出 3 倍。如果未来的研究证实了这一发现,这一发现可能表明,仪器侵入受限的硬膜外亚层空间或在该受限空间内存在桨和血肿可能是导致这种差异的原因。